Hide Board Information

Show Board Information

Easton Pharmaceuticals Inc EAPH

Board Mod: RIPPER

Asst Mods:

Last Post: 06/13/2019 4:05:41 PM

Board Marks: 21

Posts Today: 0

Board Views Today: 49

Easton Pharmaceuticals Inc. (EAPH)

Company Website: http://www.eastonpharma.com/

Easton Pharmaceuticals Inc (OTCMRKTS: EAPH) Stock Message Board

1. EAPH Company Profile

    

2. EAPH Time & Sales

    

3. EAPH Recent News

    

4. EAPH Filings

    

5. EAPH Financials

    

6. EAPH Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

2	FDA approval	RIPPER	04/21/2013 1:13:32 PM
1	unknown but going to fly this	RIPPER	04/21/2013 1:13:12 PM

Newer

Recent Articles

• NetDragon Partners with OUM to Innovate in AI Education
• Antengene Unveils Groundbreaking Preclinical Insights on ATG-201
• Insights into the Trucking Industry's Major Challenges
• Genenta Science Secures $15 Million in Direct Offering for Shares
• Genenta Science Secures $15 Million in New Direct Offering
• Innovation Highlights Eco-Friendly Products at Canton Fair
• Canton Fair Celebrates Innovative Sustainable Designs in Home Goods
• Mazdutide Achieves Significant Advances in Diabetes Treatment
• Healinno Tech's Revolutionary Robot Redefines Prostate Biopsy
• Augmentus Advances Robotics with Applied Ventures Investment
• SK hynix Unveils Revolutionary NAND Storage Strategy 2025
• Eisai and Biogen Celebrate Health Canada's Approval of LEQEMBI
• Exciting Developments from Faraday Future: New Milestones Achieved
• Vivani Medical, Inc. Secures Funding with New Stock Offering
• Investigation into Avidity Biosciences' Sale to Novartis
• POET Technologies Secures $150 Million in Investment for Growth
• Perseus Mining Reports Strong Operational Results for Q3 2025
• Secure Your Rights: Quantum Corporation Investors Must Act Now
• Investors Urged to Act Ahead of Semler Scientific Class Action
• Cygnus Metals Welcomes New CEO to Spearhead Future Growth
• Cygnus Announces Leadership Changes with New CEO Appointment
• Nyrstar NV Faces Appeal Following FSMA Sanctions Committee Ruling
• MapLight Therapeutics: Pioneering Solutions for CNS Disorders
• MapLight Therapeutics Sets Price for Its Highly Anticipated IPO
• Stay Informed: Key Legal Updates for Dow Inc. Investors
• Medtronic's Innovative Blood Pressure Treatments Show Long-Term Success
• Tronox Holdings PLC Investors Urged to Act Before Deadline
• CAPHRA's Asia Day: A Vital Approach to Tobacco Harm Reduction
• Influential Tech Leaders Shape Policy Decisions on Troops
• Transformative Financial Insights from Warren Buffett for the Elite
• Corporate Giants Fuel Trump's $300 Million Ballroom Dream
• Apple Inc. Enhances iPad Pro with Vapor Chamber Technology
• LifeMD, Inc.: Investors Encouraged to Claim Their Rights
• Breaking News: Louvre Heist Culprits Arrested in France
• Anthony Scaramucci Voices Support for Changpeng Zhao's Pardon
• General Motors Ditches CarPlay: A Shift Towards Innovation
• Exploring Trump's Bold Strategy of Gold for Bitcoin Exchange
• Cristcot Showcases Promising UC Treatment Data at Annual Meeting
• Innovative TissueCypher Test Enhances Management of Barrett's Esophagus
• Seniors Express Concerns as Social Security Payments Increase
• Castle Biosciences Unveils Key Data on TissueCypher at ACG
• Cordis Announces Innovative Results from Groundbreaking Trials
• Shaquille O'Neal's Luxury SUV Stolen in Cyber Heist
• Marex Group plc Securities Class Action Update and Guidance
• How the Fed's Balance Shift Could Impact Bitcoin Prices
• ARETI International Group Sponsors Mayflower Gran Prix 2025
• Big Week for Stocks: Major Gainers and Surprising Trends
• Microsoft's Strategic Shift in AI Development and Ethics
• U.S.-China Trade Agreement: Impact on Economy and Relations
• Recent Trends in Large Cap Stocks: Key Market Movers